-
admin
Posts
Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union
TOKYO and CAMBRIDGE, Mass., Jan. 31, 2025 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate...
Bavarian Nordic Receives Positive CHMP Opinion for Chikungunya Vaccine for Persons Aged 12 and Older
First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old. The virus-like particle (VLP) single-dose chikungunya vaccine is expected to...
SHEIN Conducted Over Two Million Product Safety Tests in 2024, Reinforces Commitment to Product Safety and Sustainability
SINGAPORE, Jan. 31, 2025 /PRNewswire/ — SHEIN today announced that it conducted over two million product safety tests in 2024, reinforcing its ongoing commitment to...
Grand Copthorne Waterfront Hotel Singapore Partners with the Royal Thai Embassy Singapore for Phuket Flavourscape Buffet
SINGAPORE, Jan. 31, 2025 /PRNewswire/ — Grand Copthorne Waterfront Hotel Singapore is pleased to announce its partnership with the Royal Thai Embassy Singapore for the...
Students from Thailand Win ‘Best in World’ Cambridge Schools Science Competition
Winners developed innovative solution to address water scarcity CAMBRIDGE, England, Jan. 31, 2025 /PRNewswire/ — The International Education group of Cambridge University Press & Assessment...
Qudian Inc. Announces Appointment of Auditor
XIAMEN, China, Jan. 31, 2025 /PRNewswire/ — Qudian Inc. (“Qudian” or “the Company” or “We”) (NYSE: QD), a consumer-oriented technology company, today announced the appointment...
BRI Officially Launches BRI UMKM EXPO(RT) 2025 and Microfinance Outlook to Empower Indonesia’s MSMEs
TANGERANG, Indonesia, Jan. 31, 2025 /PRNewswire/ — PT Bank Rakyat Indonesia (Persero) Tbk (IDX: BBRI) officially launched BRI UMKM EXPO(RT) 2025, held alongside BRI Microfinance Outlook 2025 at...
Metsera Announces Pricing of Initial Public Offering
NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) — Metsera, Inc. (Nasdaq: MTSR) (“Metsera”), a clinical-stage biotechnology company developing next-generation injectable and oral nutrient stimulated hormone...
Appendix 4C Quarterly Activity Report for Quarter Ended December 31, 2024
NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided highlights of...
Organic & Natural Health Association Endorses Robert F. Kennedy Jr. for HHS Secretary, Calls for Senate Support
WASHINGTON, Jan. 30, 2025 (GLOBE NEWSWIRE) — The Organic & Natural Health Association (Organic & Natural Health) is calling on the Senate Committee on Health,...
